| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $22.2M | +7700.0% |
| Cost of Revenue | $3.0M | — |
| R&D Expense | $93.5M | +112.2% |
| SG&A Expense | $127.1M | +226.5% |
| Operating Income | -$201.3M | -143.5% |
| Pre-tax Income | -$197.6M | -124.7% |
| Income Tax | $774K | — |
| Net Income | -$198.4M | -125.6% |
| EPS (Basic) | -$3.39 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $62.5M | +24.6% |
| Short-term Investments | $284.4M | +519.3% |
| Accounts Receivable | $15.3M | — |
| Inventory | $9.8M | — |
| Current Assets | $382.1M | +264.1% |
| Total Assets | $391.5M | +270.6% |
| Current Liabilities | $46.6M | +167.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$179.9M | -140.5% |
| Capital Expenditures | $2.5M | +615.6% |
| Investing Cash Flow | -$239.0M | -415.0% |
| Financing Cash Flow | $431.8M | +172.4% |
| Free Cash Flow | -$182.4M | -142.7% |
| +74.6% |
| EPS (Diluted) | -$3.39 | +74.6% |
| Total Liabilities |
| $50.8M |
| +191.7% |
| Stockholders' Equity | $340.6M | +325.3% |